Critical appraisal of papers reporting recommendation on sarcopenia using the AGREE II tool: a EuroAIM initiative
C Messina, JA Vitale, L Pedone, V Chianca… - European Journal of …, 2020 - nature.com
Background/objectives The growing interest of medical community about sarcopenia
resulted in the production of several clinical practice guidelines (CPGs), with an unavoidable …
resulted in the production of several clinical practice guidelines (CPGs), with an unavoidable …
Effects of different nutrition interventions on sarcopenia criteria in older people: A study protocol for a systematic review of systematic reviews with meta-analysis
LF Ferreira, J Roda Cardoso, LH Telles da Rosa - Plos one, 2024 - journals.plos.org
Background Sarcopenia, a subject of extensive research, has led to numerous clinical trials
and systematic reviews (SR). These reviews aid healthcare professionals by summarizing …
and systematic reviews (SR). These reviews aid healthcare professionals by summarizing …
[HTML][HTML] Start with muscle mass or muscle strength in diagnosis and management of sarcopenia? A systematic review of guidance documents
Y Zhang, J Guo, F Wang, C Li, K Yu - Asia Pacific Journal of …, 2024 - ncbi.nlm.nih.gov
Results Thirty-six guidance documents published between 2010 and 2023 were included.
Seven documents fulfilled≥ 50% of all the AGREE II domains. Seven underwent a Delphi …
Seven documents fulfilled≥ 50% of all the AGREE II domains. Seven underwent a Delphi …
Populations and outcome measures used in ongoing research in sarcopenia
GG Peña Ordóñez, LP Bustamante Montes… - Aging clinical and …, 2017 - Springer
Background Sarcopenia research may be hampered by the heterogeneity of populations
and outcome measures used in clinical studies. Aim The aim of this study was to describe …
and outcome measures used in clinical studies. Aim The aim of this study was to describe …
Singapore clinical practice guidelines for sarcopenia: screening, diagnosis, management and prevention
Objectives To present the local evidence and final recommendations of the Clinical Practice
Guidelines workgroup convened by the Chapter of Geriatricians and the Society for Geriatric …
Guidelines workgroup convened by the Chapter of Geriatricians and the Society for Geriatric …
How do we define and measure sarcopenia? Protocol for a systematic review
Background The loss of muscle mass is a natural aging consequence. A reduction of muscle
mass that surpasses the physiological rate is considered the key factor responsible for the …
mass that surpasses the physiological rate is considered the key factor responsible for the …
[HTML][HTML] International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management
Objectives Sarcopenia, defined as an age-associated loss of skeletal muscle function and
muscle mass, occurs in approximately 6-22% of older adults. This paper presents evidence …
muscle mass, occurs in approximately 6-22% of older adults. This paper presents evidence …
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand
Background Sarcopenia is an age‐associated skeletal muscle condition characterized by
low muscle mass, strength, and physical performance. There is no international consensus …
low muscle mass, strength, and physical performance. There is no international consensus …
The future of sarcopenia
In 2016, the 10th revision of the International Classification of Disease designated the ICD-
10-CM code for sarcopenia as M62. 84 [1]. This gave official recognition to sarcopenia as a …
10-CM code for sarcopenia as M62. 84 [1]. This gave official recognition to sarcopenia as a …